<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0004903" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Beckwith-Wiedemann syndrome</z:e> is an <z:hpo ids='HP_0001548'>overgrowth</z:hpo> disorder characterized by neonatal <z:hpo ids='HP_0001520'>macrosomia</z:hpo>, <z:hpo ids='HP_0010866'>abdominal wall defects</z:hpo>, <z:hpo ids='HP_0000158'>macroglossia</z:hpo>, <z:hpo ids='HP_0000077'>renal anomalies</z:hpo>, organomegaly, <z:hpo ids='HP_0001943'>hypoglycemia</z:hpo>, and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> predisposition </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0002884'>Hepatoblastoma</z:hpo> is the second most frequent <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> and periodic serum alpha-fetoprotein (αFP) dosage is the cornerstone of the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> surveillance for its early detection </plain></SENT>
<SENT sid="2" pm="."><plain>In this report, we describe the outstanding case of a <z:e sem="disease" ids="C0004903" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Beckwith-Wiedemann syndrome</z:e> (BWS) newborn with severe phenotype and paternal chromosome 11 <z:mp ids='MP_0008867'>uniparental disomy</z:mp> (UPD11) associated with a high <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> risk </plain></SENT>
<SENT sid="3" pm="."><plain>Based on the clinical picture and previous reports, a close monitoring of αFP was commenced </plain></SENT>
<SENT sid="4" pm="."><plain>The marker was <z:mpath ids='MPATH_458'>normal</z:mpath> immediately after birth, but rapidly raised in 20 days, leading to the diagnosis of an extremely aggressive <z:hpo ids='HP_0002884'>hepatoblastoma</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>The latter was successfully treated with pre-surgical reductive chemotherapy, gross total mass resection, and subsequent chemotherapy </plain></SENT>
<SENT sid="6" pm="."><plain>Based on this observation, the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> surveillance routinely suggested every 3 months should be more intense and with closer time intervals in newborns with severe BWS phenotype </plain></SENT>
<SENT sid="7" pm="."><plain>We suggest monitoring neonatal αFP every 20 days in such cases </plain></SENT>
</text></document>